Does OMEPRAZOLE Cause Rebound acid hypersecretion? 2,350 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,350 reports of Rebound acid hypersecretion have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 2.7% of all adverse event reports for OMEPRAZOLE.
2,350
Reports of Rebound acid hypersecretion with OMEPRAZOLE
2.7%
of all OMEPRAZOLE reports
350
Deaths
291
Hospitalizations
How Dangerous Is Rebound acid hypersecretion From OMEPRAZOLE?
Of the 2,350 reports, 350 (14.9%) resulted in death, 291 (12.4%) required hospitalization, and 16 (0.7%) were considered life-threatening.
Is Rebound acid hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 2,350 reports have been filed with the FAERS database.
What Other Side Effects Does OMEPRAZOLE Cause?
Chronic kidney disease (35,759)
Acute kidney injury (19,260)
Renal failure (14,721)
End stage renal disease (10,356)
Renal injury (9,482)
Tubulointerstitial nephritis (4,809)
Drug ineffective (4,355)
Gastrooesophageal reflux disease (3,929)
Pain (3,602)
Nephrogenic anaemia (2,873)
What Other Drugs Cause Rebound acid hypersecretion?
ESOMEPRAZOLE (2,501)
LANSOPRAZOLE (1,713)
PANTOPRAZOLE (1,581)
DEXLANSOPRAZOLE (1,160)
OMEPRAZOLE\SODIUM BICARBONATE (95)
RABEPRAZOLE (64)
RANITIDINE (29)
FAMOTIDINE (12)
ESOMEPRAZOLE\NAPROXEN (9)
Which OMEPRAZOLE Alternatives Have Lower Rebound acid hypersecretion Risk?
OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE
OMEPRAZOLE vs OMNIPAQUE
OMEPRAZOLE vs OMNISCAN
OMEPRAZOLE vs ONABOTULINUMTOXINA
OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC